Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment

Author(s): Rama Rao Malla* and Mohammad Amjad Kamal

Volume 28, Issue 28, 2021

Published on: 09 December, 2020

Page: [5674 - 5698] Pages: 25

DOI: 10.2174/0929867328666201209100659

Price: $65

conference banner
Abstract

The breast tumor microenvironment (TME) promotes drug resistance through an elaborated interaction of TME components mediated by reactive oxygen species (ROS). Although there is massive accumulation of data concerning the targeting of the ROS, little is known about the ROS-responsive nanomedicine for targeting breast TME. This review submits the ROS landscape in breast TME, including ROS biology, ROS mediated carcinogenesis, and reprogramming of stromal and immune cells of TME. We also discussed ROS-based precision strategies for imaging TME, including molecular imaging techniques with advanced probes, multiplexed methods, and multi-omic profiling strategies. ROS-responsive nanomedicine also describes various therapies, such as chemo- dynamic, photodynamic, photothermal, sono-dynamic, immune, and gene therapy for BC. We expound ROS-responsive primary delivery systems for chemotherapeutics, phytochemicals, and immunotherapeutics. This review also presents recent updates on nanotheranostics for simultaneous diagnosis and treatment of BCs. We assume that a review on this advancing field will be beneficial to the development of ROS-based nano-theranostics for BC.

Keywords: Breast cancer, nanotechnology, precision medicine, ROS biology, tumor microenvironment, ROS mediated carcinogenesis.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy